• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Congrats Michel! Highest compensation pay for yourself! 18.7 Mil

















Isn't Biogen supposed to be a leading science company in neurology? Maybe a biotech run by a salesman with a company linkedin profile full of (fictitious) social virtue posts has lost its focus. Five years after Scangos, any new drugs from internal R&D or forward progress from a CEO who has taken home 50M+ while internal talent fled? Can the analysts be honest here or do the club insider rules prohibit it?

Congratulations on a great quarter with revenue down 25 percent. Thank you for calling on me for a question and I look forward to attending your next party. Can you update us on daclizumab?